Summary
Latest filing:
Behzad Aghazadeh is Director, 10% Owner of Scribe Therapeutics, Inc. (SCTX). 3 SEC Form 4 filings on record, most recently on 29 July 2026. Most recent open-market trade: bought $144K of SCTX on 29 July 2026. Lifetime open-market purchases: $36.26M.
Recent Transactions
3Every recent SEC Form 4 transaction Behzad Aghazadeh has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Behzad Aghazadeh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $15.00M of SCTX open-market activity in the last 12 months
- Carl L. Gordon - $15.00M of SCTX open-market activity in the last 12 months
- AH Bio Fund II, L.P. - $5.00M of SCTX open-market activity in the last 12 months
- Svetlana Lucas - $45K of SCTX open-market activity in the last 12 months
- David Parrot - $40K of SCTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Behzad Aghazadeh?
Behzad Aghazadeh is a corporate insider, tracked as Director, 10% Owner of Scribe Therapeutics, Inc. (SCTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Behzad Aghazadeh submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Behzad Aghazadeh been buying or selling stock?
Recorded transactions: 3 open-market purchases ($36.26M) and 0 open-market sales across all tracked filings.
Where can I see all of Behzad Aghazadeh's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Behzad Aghazadeh and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
